Tine N. Alver
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Gut microbiota alterations in patients with non-small-cell lung cancer undergoing chemoradiotherapy.
Gut microbiota alterations in patients with non-small-cell lung cancer undergoing chemoradiotherapy.
Journal: Molecular oncology
Published: March 23, 2026
Systematic interrogation of drug sensitivities in melanoma reveals potent synergistic and antagonistic drug combinations with translational potential.
Journal: Communications medicine
Published: August 25, 2025
Spatial Transcriptomics Reveals Cancer and Stromal Cell Heterogeneity Between Center and Invasive Front of Pancreatic Cancer.
Journal: Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc
Published: June 21, 2024
Thoracic radiation in combination with erlotinib-results from a phase 2 randomized trial.
Journal: Frontiers in oncology
Published: April 05, 2024
Atezolizumab and stereotactic body radiotherapy in patients with advanced non-small cell lung cancer: safety, clinical activity and ctDNA responses-the ComIT-1 trial.
Journal: Molecular oncology
Published: May 20, 2022
Cooperative induction of receptor tyrosine kinases contributes to adaptive MAPK drug resistance in melanoma through the PI3K pathway.
Journal: Cancer reports (Hoboken, N.J.)
Published: January 11, 2022
Dysregulation of MITF Leads to Transformation in MC1R-Defective Melanocytes.
Journal: Cancers
Published: May 25, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026